PCOTEOTHU
MRNA icon

Provident Company of the Employees of the Hebrew University’s Moderna MRNA Stock Holding History

Provident Company of the Employees of the Hebrew University’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,463
Closed -$485K – 33
2025
Q4 		$485K Hold
16,463
– – 0.5% 30
2025
Q3 		$424K Hold
16,463
– – 0.42% 30
2025
Q2 		$454K Hold
16,463
– – 0.45% 30
2025
Q1 		$466K Buy
16,463
+350
+2% +$12.4K 0.54% 31
2024
Q4 		$669K Sell
16,113
-4,097
-20% -$196K 0.78% 27
2024
Q3 		$1.35M Buy
20,210
+7,245
+56% +$665K 1.52% 25
2024
Q2 		$1.54M Buy
12,965
+22
+0.2% +$2.78K 1.83% 22
2024
Q1 		$1.38M Buy
+12,943
New +$1.3M 1.46% 25

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Provident Company of the Employees of the Hebrew University's MRNA Position: Q1 2026 in Review

Provident Company of the Employees of the Hebrew University sold out of Moderna (MRNA) in Q1 2026, closing a stake of 16,463 shares — an estimated $485K sold.

Provident Company of the Employees of the Hebrew University first reported a position in MRNA in Q1 2024 and held it in 8 quarters. The position peaked at $1.54M in Q2 2024. 723 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Provident Company of the Employees of the Hebrew University reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
  • Provident Company of the Employees of the Hebrew University sold 16,463 Moderna shares in Q1 2026, an estimated $485K.
  • Provident Company of the Employees of the Hebrew University first reported a position in Moderna in Q1 2024 and held it in 8 quarters.
  • Provident Company of the Employees of the Hebrew University's Moderna position peaked at $1.54M in Q2 2024.
  • 723 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Provident Company of the Employees of the Hebrew University's 13F filing for Q1 2026, filed 12 May 2026.